IL-22 has been suggested to play a protective role in the disease by inhibiting CD4+ T cell migration and collagen deposition [36] and the decrease in IL-22 in the TLR2/9-/- mice may explain the development of granulomas despite decreased T cell activation and TNFα production in these mice. The gene discussed is IL22; the disease is Granuloma.